Free Trial

Personalis (PSNL) Competitors

Personalis logo
$9.45 +0.52 (+5.82%)
Closing price 04:00 PM Eastern
Extended Trading
$9.44 0.00 (-0.05%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PSNL vs. HTFL, VCYT, CON, SGRY, GRAL, ADUS, ARDT, LFST, CELC, and PACS

Should you be buying Personalis stock or one of its competitors? The main competitors of Personalis include Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), GRAIL (GRAL), Addus HomeCare (ADUS), Ardent Health (ARDT), LifeStance Health Group (LFST), Celcuity (CELC), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

Personalis vs. Its Competitors

Personalis (NASDAQ:PSNL) and Heartflow (NASDAQ:HTFL) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

Heartflow has a net margin of 0.00% compared to Personalis' net margin of -113.70%. Heartflow's return on equity of 0.00% beat Personalis' return on equity.

Company Net Margins Return on Equity Return on Assets
Personalis-113.70% -47.57% -35.05%
Heartflow N/A N/A N/A

Heartflow has lower revenue, but higher earnings than Personalis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Personalis$84.61M9.90-$81.28M-$1.28-7.38
HeartflowN/AN/AN/AN/AN/A

Personalis presently has a consensus target price of $8.25, indicating a potential downside of 12.70%. Heartflow has a consensus target price of $36.60, indicating a potential downside of 8.29%. Given Heartflow's higher possible upside, analysts clearly believe Heartflow is more favorable than Personalis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Personalis
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71
Heartflow
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

61.9% of Personalis shares are owned by institutional investors. 3.8% of Personalis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Personalis had 3 more articles in the media than Heartflow. MarketBeat recorded 12 mentions for Personalis and 9 mentions for Heartflow. Personalis' average media sentiment score of 0.56 beat Heartflow's score of 0.56 indicating that Personalis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Personalis
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Heartflow
2 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Personalis beats Heartflow on 7 of the 11 factors compared between the two stocks.

Get Personalis News Delivered to You Automatically

Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PSNL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PSNL vs. The Competition

MetricPersonalisMED IndustryMedical SectorNASDAQ Exchange
Market Cap$838.03M$4.29B$6.17B$10.66B
Dividend YieldN/A0.88%5.72%4.86%
P/E Ratio-7.3811.2429.6328.51
Price / Sales9.9020.63578.55129.15
Price / CashN/A7.1937.1261.42
Price / Book3.294.3312.046.52
Net Income-$81.28M-$134.23M$3.32B$276.75M
7 Day Performance-8.07%0.05%-0.16%0.20%
1 Month Performance54.66%12.93%5.76%1.67%
1 Year Performance101.49%71.45%65.69%32.72%

Personalis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PSNL
Personalis
2.9035 of 5 stars
$9.45
+5.8%
$8.25
-12.7%
+90.0%$838.03M$84.61M-7.38400News Coverage
Analyst Forecast
Gap Down
HTFL
Heartflow
N/A$33.22
-0.7%
$36.60
+10.2%
N/A$2.79BN/A0.00699News Coverage
VCYT
Veracyte
3.9181 of 5 stars
$34.09
-2.0%
$40.90
+20.0%
+6.6%$2.74B$445.76M103.31790Analyst Forecast
CON
Concentra Group Holdings Parent
2.5481 of 5 stars
$20.17
-0.7%
$27.75
+37.6%
-2.3%$2.60B$1.90B16.9511,250
SGRY
Surgery Partners
3.7523 of 5 stars
$19.79
+0.3%
$32.00
+61.7%
-32.6%$2.53B$3.11B-13.8415,000Positive News
GRAL
GRAIL
0.6688 of 5 stars
$70.44
+6.5%
$56.67
-19.6%
+458.9%$2.38B$125.60M-5.371,360Analyst Forecast
ADUS
Addus HomeCare
4.733 of 5 stars
$112.58
-0.3%
$137.50
+22.1%
-6.6%$2.08B$1.15B24.8549,703Positive News
ARDT
Ardent Health
3.3366 of 5 stars
$14.10
+0.4%
$19.33
+37.1%
-23.4%$2.01B$5.97B7.7924,900
LFST
LifeStance Health Group
3.5344 of 5 stars
$5.11
+1.2%
$8.50
+66.3%
-29.7%$1.96B$1.25B-102.2010,218News Coverage
CELC
Celcuity
1.7813 of 5 stars
$47.41
+2.9%
$56.50
+19.2%
+328.4%$1.95BN/A-13.7440Analyst Forecast
PACS
PACS Group
2.3607 of 5 stars
$12.36
-2.8%
$26.25
+112.4%
-69.8%$1.94B$3.11B0.0032,433News Coverage

Related Companies and Tools


This page (NASDAQ:PSNL) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners